SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function
Authors
Keywords
-
Journal
NEUROBIOLOGY OF DISEASE
Volume 178, Issue -, Pages 106022
Publisher
Elsevier BV
Online
2023-01-27
DOI
10.1016/j.nbd.2023.106022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
- (2022) Sabrina Paganoni et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
- (2022) Sabrina Paganoni et al. MUSCLE & NERVE
- NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
- (2022) Barış Genç et al. Scientific Reports
- Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy
- (2022) Mukesh Gautam et al. Scientific Reports
- Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval
- (2022) Young-A Heo CNS DRUGS
- Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
- (2022) Benjamin Rix Brooks et al. PLoS One
- Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch
- (2022) Angela Genge et al. DRUGS IN R&D
- The Dying Forward Hypothesis of ALS: Tracing Its History
- (2021) Andrew Eisen Brain Sciences
- Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP‐43 pathology
- (2021) Barış Genç et al. Clinical and Translational Medicine
- Mitochondrial Metabolism Regulation of T Cell–Mediated Immunity
- (2021) Elizabeth M. Steinert et al. Annual Review of Immunology
- Cardiolipin, Mitochondria, and Neurological Disease
- (2021) Micol Falabella et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Upper and Lower Motor Neuron Degenerations Are Somatotopically Related and Temporally Ordered in the Sod1 Mouse Model of Amyotrophic Lateral Sclerosis
- (2021) Christine Marques et al. Brain Sciences
- Neurophysiological Mechanisms Underlying Cortical Hyper-Excitability in Amyotrophic Lateral Sclerosis: A Review
- (2021) Jonu Pradhan et al. Brain Sciences
- The Cortical “Upper Motoneuron” in Health and Disease
- (2021) Roger N. Lemon Brain Sciences
- Amyotrophic lateral sclerosis is a systemic disease
- (2021) Stanley H. Appel et al. CURRENT OPINION IN NEUROLOGY
- Mitochondrial function in development and disease
- (2021) Marlies P. Rossmann et al. Disease Models & Mechanisms
- TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- (2021) Fiona Bright et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons
- (2021) Barış Genç et al. GENE THERAPY
- Mitochondrial Diseases: Hope for the Future
- (2020) Oliver M. Russell et al. CELL
- Mitochondrial DNA in inflammation and immunity
- (2020) Joel S Riley et al. EMBO REPORTS
- The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action
- (2020) Wayne Mitchell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis
- (2020) Aurore Brunet et al. Frontiers in Neuroscience
- Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology
- (2020) Zeynep I. Gunes et al. Frontiers in Neuroscience
- The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats
- (2020) Mitchell E. Allen et al. Communications Biology
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
- (2020) Sabrina Paganoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondrial complex III is essential for suppressive function of regulatory T cells
- (2019) Samuel E. Weinberg et al. NATURE
- NAD-biosynthetic pathways regulate innate immunity
- (2019) Leah K. Billingham et al. NATURE IMMUNOLOGY
- TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response
- (2019) Peng Wang et al. PLoS Genetics
- Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin
- (2019) Angelique Camilleri et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Mitochondria as central hub of the immune system
- (2019) Cristiane Naffah de Souza Breda et al. Redox Biology
- MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology
- (2019) Javier H. Jara et al. Journal of Neuroinflammation
- TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration
- (2019) Ju Gao et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Mitoautophagy: A Unique Self-Destructive Path Mitochondria of Upper Motor Neurons With TDP-43 Pathology Take, Very Early in ALS
- (2019) Mukesh Gautam et al. Frontiers in Cellular Neuroscience
- Incorporating upper motor neuron health in ALS drug discovery
- (2018) Ina Dervishi et al. DRUG DISCOVERY TODAY
- TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics
- (2018) Stephani A. Davis et al. NEUROSCIENCE LETTERS
- Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology
- (2018) Mukesh Gautam et al. ACTA NEUROPATHOLOGICA
- Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging
- (2018) Hazel H. Szeto et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Stealth Peptides Target Cellular Powerhouses to Fight Rare and Common Age-Related Diseases
- (2018) Hazel H. Szeto PROTEIN AND PEPTIDE LETTERS
- Drug discovery for hearing loss: Phenotypic screening of chemical compounds on primary cultures of the spiral ganglion
- (2017) Donna S. Whitlon HEARING RESEARCH
- Evidence for an early innate immune response in the motor cortex of ALS
- (2017) Javier H. Jara et al. Journal of Neuroinflammation
- Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
- (2017) Matthew D. Cykowski et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis
- (2016) Jayden A. Clark et al. JOURNAL OF CHEMICAL NEUROANATOMY
- The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity
- (2016) Wenzhang Wang et al. NATURE MEDICINE
- Pathophysiological and diagnostic implications of cortical dysfunction in ALS
- (2016) Nimeshan Geevasinga et al. Nature Reviews Neurology
- Structure and function of mitochondrial membrane protein complexes
- (2015) Werner Kühlbrandt BMC BIOLOGY
- Regulation of mitochondrial transport in neurons
- (2015) Mei-Yao Lin et al. EXPERIMENTAL CELL RESEARCH
- Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse
- (2015) Ken Ikeda et al. PLoS One
- Cortical Function in Asymptomatic Carriers and Patients WithC9orf72Amyotrophic Lateral Sclerosis
- (2015) Nimeshan Geevasinga et al. JAMA Neurology
- Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity
- (2014) H H Szeto et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex
- (2014) G. M. Thomsen et al. JOURNAL OF NEUROSCIENCE
- TDP-43 in ALS: Stay on Target…Almost There
- (2014) Ana Jovičić et al. NEURON
- Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms
- (2013) John K. Fink ACTA NEUROPATHOLOGICA
- First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics
- (2013) Hazel H Szeto BRITISH JOURNAL OF PHARMACOLOGY
- Mildronate, the inhibitor of l-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation
- (2013) Marina Makrecka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons
- (2013) Wenzhang Wang et al. HUMAN MOLECULAR GENETICS
- eGFP Expression under UCHL1 Promoter Genetically Labels Corticospinal Motor Neurons and a Subpopulation of Degeneration-Resistant Spinal Motor Neurons in an ALS Mouse Model
- (2013) M. V. Yasvoina et al. JOURNAL OF NEUROSCIENCE
- Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
- (2013) Shuo-Chien Ling et al. NEURON
- Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II
- (2012) Maria Sofia Cotelli et al. MUSCLE & NERVE
- The Cardioprotective Effect of Mildronate is Diminished After Co-Treatment With l-Carnitine
- (2011) Janis Kuka et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The role of mitochondria in neurodegenerative diseases
- (2011) Massimiliano Filosto et al. JOURNAL OF NEUROLOGY
- Roles of mitochondria in human disease: Figure 1
- (2010) Michael R. Duchen et al. Essays in Biochemistry
- The “Dying-Back” Phenomenon of Motor Neurons in ALS
- (2010) Michal Dadon-Nachum et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
- (2010) Y.-F. Xu et al. JOURNAL OF NEUROSCIENCE
- TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
- (2009) I. Wegorzewska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Descending Pathways in Motor Control
- (2008) Roger N. Lemon Annual Review of Neuroscience
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
- (2008) Hidefumi Ito et al. EXPERIMENTAL NEUROLOGY
- Structural determinants of the cellular localization and shuttling of TDP-43
- (2008) Y. M. Ayala et al. JOURNAL OF CELL SCIENCE
- Mitochondrial Membrane Potential in Axons Increases with Local Nerve Growth Factor or Semaphorin Signaling
- (2008) J. Verburg et al. JOURNAL OF NEUROSCIENCE
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
- (2008) J. Sreedharan et al. SCIENCE
- EDARAVONE INHIBITS THE INDUCTION OF INOS GENE EXPRESSION AT TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL STEPS IN MURINE MACROPHAGES
- (2008) Hideyuki Yoshida et al. SHOCK
- Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
- (2007) Emanuele Buratti Frontiers in Bioscience-Landmark
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started